Absolute Antibody Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Absolute Antibody Ltd. - overview

Established

2012

Location

-, North Yorkshire, UK

Primary Industry

Biotechnology

About

Founded in 2012 and based in the UK, Absolute Antibody Ltd. is a biotechnology company that offers antibody sequencing, engineering and recombinant development of antibodies to pharmaceutical, biotechnology and diagnostics companies.


Current Investors

Thompson Street Capital Partners, Absolute Biotech

Primary Industry

Biotechnology

Sub Industries

Bioinformatics, Molecular Science, Genetics & Gene Therapy

Website

www.absoluteantibody.com

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

Absolute Antibody Ltd. - financials

Fiscal Year EndedAug 31, 2018Aug 31, 2019Aug 31, 2020
Revenue (USD)---
% Revenue Growth (YoY)---
EBITDA (USD)---
Operating Income (USD)---
Operating Margin---
% EBITDA Margin---
NET Income (USD)---
% Net Margin---

Absolute Antibody Ltd. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedAbsolute Antibody Ltd.-

Displaying 1 - 1 of 1

Absolute Antibody Ltd. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.